Otothera Corporation
Stage
Incubator/Accelerator | AliveAbout Otothera Corporation
Otothera Corporation is a medical device company developing products to diagnose and treat the more than seven million severe tinnitus (constant ringing in the ears) sufferers in the US. The company was originally named AudioFusion. The company was a 2006 PTEN Growth Accelerator (GAP) winner.
Missing: Otothera Corporation's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Otothera Corporation's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Otothera Corporation Frequently Asked Questions (FAQ)
What is Otothera Corporation's latest funding round?
Otothera Corporation's latest funding round is Incubator/Accelerator.
Who are the investors of Otothera Corporation?
Investors of Otothera Corporation include Babcock Demon Incubator.
Who are Otothera Corporation's competitors?
Competitors of Otothera Corporation include Intellirod Spine, HyperMed Imaging, Avantis Medical Systems, Samsara Vision, Corpora Systems and 13 more.
Compare Otothera Corporation to Competitors
ImpediMed is a medical device company focusing on bioimpedance.
PPI was formed from the merger of three companies (MPI International, Skill Tool & Die, and Precision Gear) to manufacture complex, high-precision metal components for the automotive, defense, medical device and construction industries.
CeloNova BioSciences is a global medical device company that develops, manufactures and markets a family of interventional cardiology and endovascular products, including its proprietary COBRA PzF Coronary Stent System. The company's interventional cardiology and endovascular products are currently available in more than fifty countries.
Cerene Biomedics is developing an implantable medical device that will prevent epileptic seizures
NeuroTrax is a medical device and technology company.
Moximed is a developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis (OA). The Moximed implants do not require bone cutting or bone removal, and, importantly, they absorb excess joint load rather than shift load to other areas of the joint. The company is based in Fremont, California.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.